[Selectively antimetastatic effects of aryltriazene methoxypyrimidine on Lewis lung carcinoma].
D000818:Animals; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D051379:Mice; D011961:Receptors, Fc / Q000187:drug effects; D014226:Triazenes / Q000627:therapeutic use*
D011961:Receptors, Fc; D014226:Triazenes; C050783:4-(4-(3,3-dimethyl-1-triazene)-phenylsulfamide)-5,6-dimethoxypyrimidine